Abstract
Peplomycin (PEP), an anti-tumor antibiotic related structurally to bleomycin, is widely used, especially for squamous cell carcinoma but shows renal toxicity. We prepared monoclonal antibodies (mAbs) against N-(γ-maleimidobutyryloxy)succinimide-conjugated PEP. The mAbs were monospecific for PEP, but did not react with bleomycin and other anticancer antibiotics. The mAbs enabled us to develop an immunocytochemical (ICC) method for detecting the uptake of PEP in the rat kidney. Two hours after a single i.v. administration of PEP, ICC revealed immunostaining for PEP in irregularly shaped cytoplasmic granules of the proximal tubules in which the microvilli were also stained. Also, staining occurred in the distal tubules and collecting ducts, in both of which we observed scattered swollen cells, reminiscent of necrotic cells, in which both the nuclei and cytoplasm reacted strongly with the antibody. Twenty-four hours after injection, PEP in the proximal tubules completely vanished, but yet significant amounts of PEP remained in both the distal tubules and collecting ducts. Distribution patterns of PEP in cells of the kidneys resembled, in some ways, those of our recent ICC studies for an organic cation aminoglycoside antibiotic gentamicin. This ICC suggests that PEP taken up in the proximal tubule cells is localized in the lysosomes, and organic cation transporters and bleomycin hydrolase might be involved in entrance and/or disappearance of PEP in this cell type. Furthermore, the distal tubules and collecting ducts may be the sites readily affected by some chemotherapeutic agents.
Similar content being viewed by others
Abbreviations
- PEP:
-
Peplomycin
- BLM:
-
Bleomycin
- DM:
-
Daunomycin
- GM:
-
Gentamicin
- ICC:
-
Immunocytochemistry
- BSA:
-
Bovine serum albumin
- APEP mAbs:
-
Anti-peplomycin monoclonal antibodies
- HRP:
-
Horseradish peroxidase
- PBS:
-
Phosphate-buffered saline
- RT:
-
Room temperature
- GA:
-
Glutaraldehyde
- ELISA:
-
Enzyme-linked immunosorbent assay
- GMBS:
-
N-(γ-Maleimidobutyryloxy)succinimide
References
Azambuja E, Fleck JF, Batista RG, Menna Barreto SS (2005) Bleomycin lung toxicity: who are the patients with increased risk? Pulm Pharmacol Ther 18(5):363–366
Beauchamp D, Beauchamp D, Gourde P, Bergeron MG (1991) Subcellular distribution of gentamicin in proximal tubular cells, determined by immunogold labeling. Antimicrob Agents Chemother 35:2173–2179
Beauchamp D, Gourde P, Simard M, Bergeron MG (1992) Subcellular localization of tobramycin and vancomycin given alone and in combination in proximal tubular cells, determined by immunogold labeling. Antimicrob Agents Chemother 36:2204–2210
Bergeron MG, Marois Y, Kuehn C, Silverblatt FJ (1987) Autoradiographic study of tobramycin uptake by proximal and distal tubules of normal and pyelonephritic rats. Antimicrob Agents Chemother 31:1359–1364
Chen J, Stubbe J (2005) Bleomycins: towards better therapeutics. Nat Rev Cancer 5(2):102–112
Dobson PD, Kell DB (2008) Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule? Nat Rev Drug Discov 7(3):205–220
Efstathiou E, Logothetis CJ (2006) Review of late complications of treatment and late relapse in testicular cancer. J Natl Compr Canc Netw 4(10):1059–1070
Fujiwara K, Masuyama Y (1995) Monoclonal antibody against the glutaraldehyde-conjugated polyamine, spermine. Histochem Cell Biol 104:309–316
Fujiwara K, Yasuno M, Kitagawa T (1981) Enzyme immunoassay for pepleomycin, a new bleomycin analog. Cancer Res 41:4121–4126
Fujiwara K, Takatsu H, Tsukamoto K (2005) Immunocytochemistry for drugs containing an aliphatic amino group in the molecule, anticancer antibiotic daunomycin as a model. J Histochem Cytochem 53:467–474
Fujiwara K, Shin M, Hougaard D, Larsson L-I (2007) Distribution of anticancer antibiotic daunomycin in the rat heart and kidney revealed by immunocytochemistry using monoclonal antibodies. Histochem Cell Biol 127:69–77
Fujiwara K, Shin M, Matsunaga H, Saita T, Larsson LI (2009) Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney. Antimicrob Agents Chemother 53(8):3302–3307
Giuliano RA, Paulus GJ, Verpooten GA, Tattyn V, Pollet DE, Tulkens PM, de Broe ME (1984) Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats. Kidney Int 26:838–847
Giurgea-Marion L, Toubeau G, Laurent G, Heuson-Stiennon JA, Tulkens PM (1986) Impairment of lysosome–pinocytic vesicle fusion in rat kidney proximal tubules after treatment with gentamicin at low doses. Toxicol Appl Pharmacol 86:271–285
Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multi-drug transporter. Annu Rev Biochem 62:385–427
Graham RC, Karnovsky NJ (1966) The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney. Ultrastructural cytochemistry by a new technique. J Histochem Cytochem 14:291–302
Inui K, Masuda S, Saito H (2000) Cellular and molecular aspects of drug transport in the kidney. Kidney Int 58:944–958
Isaka K, Akaeda T, Itoh H, Hori K, Yudate T, Nagata J, Suzuki Y, Takayama M (2002) Dysgerminoma in a patient with a tumor of the neck. Empiric treatment of stage IV dysgerminoma. Gynecol Obstet Investig 54(2):109–113
Kamata Y, Taniguchi A, Yamamoto M, Nomura J, Ishihara K, Takahara H, Hibino T, Takeda A (2009) Neutral cysteine protease bleomycin hydrolase is essential for the breakdown of deiminated filaggrin into amino acids. J Biol Chem 284:12829–12836
Koldamova RP, Lefterov IM, DiSabella MT, Almonte C, Watkins SC, Lazo JS (1999) Human bleomycin hydrolase binds ribosomal proteins. Biochemistry 38:7111–7117
Laurent G, Carlier MB, Rollmann B, Van Hoff F, Tulkens PM (1982) Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem Pharmacol 31:3861–3870
Liu Y, Sakagami H, Kukuchi H, Nakamura Y, Ishihara M, Kanda Y, Kunii S, Zhang W, Yu G (2008) Tumor-specific cytotoxicity and type of cell death induced by peplomycin in oral squamous cell carcinoma cell lines. Anticancer Res 28:2197–2204
Luft FCL, Rankin LI, Sloan RS, Yum MN (1978) Recovery from aminoglycoside nephrotoxicity with continued drug administration. Antimicrob Agents Chemother 14:284–287
McKinney JD (1988) Renal transport of organic anions and cations. In: Schreier RW, Gottschalk CW (eds) Diseases of the kidney. Little, Brown and Company, Boston, MA, pp 285–307
Motoyama S, Hamana S, Ku Y, Laoag-Fernandez JB, Deguchi M, Yoshida S, Tominaga M, Iwasaki T, Ohara N, Maruo T (2004) Neoadjuvant high-dose intraarterial infusion chemotherapy under percutaneous pelvic perfusion with extracorporeal chemofiltration in patients with stages IIIa–IVa cervical cancer. Gynecol Oncol 95(3):576–582
Mountfield RJ, Kiehr B, John BA (2000) Metabolism, disposition, excretion, and pharmacokinetics of levormeloxifene, a selective estrogen receptor modulator, in the rat. Drug Metab Dispos 28:503–513
Nishihara K, Masuda S, Ji L, Katsura T, Inui K (2007) Pharmacokinetic significance of luminal multidrug and toxin extrusion 1 in chronic renal failure rats. Biochem Pharmacol 73:1482–1490
Ohara K, Shin M, Larsson L-I, Fujiwara K (2007a) Improved immunocytochemical detection of daunomycin. Histochem Cell Biol 127:603–608
Ohara K, Shin M, Nakamuta H, Larsson L-I, Hougaard DM, Fujiwara K (2007b) Immunocytochemical studies on the distribution pattern of daunomycin in rat gastrointestinal tract. Histochem Cell Biol 128:285–290
Peng L, Nimni ME (1999) Delivery of erythromycin to subcutaneous tissues in rats by means of trans-phase delivery system. J Pharm Pharmacol 51:1135–1141
Schaub TP, Kartenbeck J, König J, Vogel O, Witzgall R, Kriz W, Keppler D (1997) Expression of the conjugate export pump encoded by the mrp2 gene in the apical membrane of kidney proximal tubules. J Am Soc Nephrol 8(8):1213–1221
Shin M, Larsson L-I, Hougaard DM, Fujiwara K (2009) Daunomycin accumulation and induction of programmed cell death in rat hair follicles. Cell Tissue Res 337:429–438
Shin M, Matsunaga H, Fujiwara K (2010) Differences in accumulation of anthracyclines daunorubicin, doxorubicin and epirubicin in rat tissues revealed by immunocytochemistry. Histochem Cell Biol 133:677–682
Sikic BI, Siddik ZH, Gram TE (1980) Relative pulmonary toxicity and antitumor effects of 2 new bleomycin analogs, pepleomycin and tallysomycin-A. Cancer Treat Rep 64:659–668
Sokol PP, Huiatt KR, Holohan PD, Ross CR (1989) Gentamicin and verapamil compete for a common transport mechanism in renal brush border membrane vesicles. J Pharmacol Exp Ther 251:937–942
Sugawara I, Kataoka I, Morishita Y, Hamada H, Tsuruo T, Itoyama S, Mori S (1988) Tissue distribution of p-glycoprotein encoded by a multidrug-resistant gene as revealed by a monoclonal antibody, MRK 16. Cancer Res 48:1926–1929
Takahashi S, Hirose Y, Ikeda E, Fukaya R, Kawase T (2007) Chromosome arm 1q gain associated with good response to chemotherapy in a malignant glioma. Case report. J Neurosurg 106(3):488–494
Takeda A, Higuchi D, Yamamoto T, Nakamura Y, Masuda Y, Hirabayashi T, Nakaya K (1996) Purification and characterization of bleomycin hydrolase, which represents a new family of cysteine proteases, from rat skin. J Biochem 119:29–36
Takimoto CH, Calvo E (2008) Principles of oncologic pharmacotherapy. In: Pazdur R, Wagman LD, Camphausen KA, and Hoskins WJ (eds) Cancer management: a multidisciplinary approach, 11th edn. http://Cancernetwork.com
Tanihara Y, Masuda S, Sato T, Katsura T, Ogawa O, Inui K (2007) Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H+-organic cation antiporters. Biochem Pharmacol 74:359–371
Terada T, Inui K (2008) Physiological and pharmacokinetic roles of H+/organic cation antiporters (METE/SLC47A). Biochem Pharmacol 75:1689–1696
Terada T, Masuda S, Asaka J, Tsuda M, Katsura T, Inui K (2006) Molecular cloning, functional characterization and tissue distribution of rat H+ antiporter MATE1. Pharm Res 23:1696–1701
Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735–7738
Umebayashi Y, Enomoto H, Ogasawara M (2004) Drug eruption due to peplomycin: an unusual form of Stevens-Johnson syndrome with pustules. J Dermatol 31:802–805
Umezawa H (1976) Structure and action of bleomycin. Prog Biochem Pharmacol 11:18–27
Wedeen RP, Batuman V, Cheeks C, Marquet E, Sobel H (1983) Transport of gentamicin in rat proximal tubule. Lab Invest 48:212–223
Acknowledgments
We are grateful to Y Teruya, N Kiriyama, M Takauye, Y Yamashita, S Ishii, and T Kawazoye for technical assistance throughout this study.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
418_2010_768_MOESM1_ESM.jpg
Fig. 1a-d. Immunostaining for PEP in the kidneys of rats 2 h (a, b, d) or 24 h (c) after PEP injection in a single intravenous dose (5 mg/kg of body weight). In ICC, enzyme digestion of section specimens was carried out with 0.004% protease at 30°C for 2 h (a, b, d) or 15 min (c). (a) Lower magnification of the renal cortex. Note that immunostaining pattern was essentially the same as that of Fig. 5a. (b) Higher magnification of the S1 and S2 segment of the proximal tubule cells. Note that immunostaining pattern was essentially the same as that of Fig. 4c. (c) Note staining occurs in the distal tubule cells in which some swollen, necrotic-like cells (arrows) are heavily stained, but not at all in the proximal tubule cells. This pattern was essentially the same as that of Fig. 4e. (d) The staining (b) was completely abolished by absorption of APEP 51-35 with 10 µg/ml of PEP. G, glomerulus; P, proximal tubule; D, distal tubule. Bars = 100 µm (a); 20 µm (b, c, d) (JPEG 1607 kb)
418_2010_768_MOESM2_ESM.jpg
Fig. 2a-c. Immunostaining for GM in the kidneys of rats 24 h (a, b) or 12 h (c) after GM injection in a single intravenous dose (16 mg/kg of body weight). In ICC, enzyme digestion of section specimens was carried out with 0.004% protease at 30°C for 2 h (a, b) or 15 min (c). (a) Lower magnification of the renal cortex. Immunostaining is strong in the S1 and S2 segments of the proximal tubules and weak in the S3 segment (medullary portions of the straight proximal tubule). (b) Higher magnification of the renal cortex. Note strong immunostaining of cytoplasmic granules in proximal tubule cells and weak staining in the nuclei of the distal tubule cells. (c) The nuclei as well as the cytoplasm of cells of the distal convoluted tubules are immunostained for GM. Note no staining cells (arrowheads) next to the heavily immunostained cells (arrows). The proximal tubule cells are GM-negative under this ICC conditions. G, glomerulus; P, proximal tubule; D, distal tubule. Bars = 100 µm (a); 20 µm (b, c) (JPEG 1349 kb)
Rights and permissions
About this article
Cite this article
Fujiwara, K., Shin, M., Hougaard, D.M. et al. Distribution study of peplomycin in rat kidney revealed by immunocytochemistry using monoclonal antibodies. Histochem Cell Biol 135, 93–101 (2011). https://doi.org/10.1007/s00418-010-0768-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00418-010-0768-9